Free Trial
NASDAQ:MDCX

Medicus Pharma (MDCX) Stock Price, News & Analysis

Medicus Pharma logo
$3.13 +0.10 (+3.30%)
As of 07/14/2025 04:00 PM Eastern

About Medicus Pharma Stock (NASDAQ:MDCX)

Key Stats

Today's Range
$2.95
$3.14
50-Day Range
$2.34
$7.78
52-Week Range
$1.80
$8.94
Volume
479,666 shs
Average Volume
192,258 shs
Market Capitalization
$42.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.50
Consensus Rating
Strong Buy

Company Overview

Medicus Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

MDCX MarketRank™: 

Medicus Pharma scored higher than 44% of companies evaluated by MarketBeat, and ranked 655th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medicus Pharma has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Medicus Pharma has only been the subject of 2 research reports in the past 90 days.

  • Read more about Medicus Pharma's stock forecast and price target.
  • Earnings Growth

    Earnings for Medicus Pharma are expected to decrease in the coming year, from ($1.14) to ($1.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medicus Pharma is -2.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medicus Pharma is -2.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Medicus Pharma has a P/B Ratio of 10.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Medicus Pharma's valuation and earnings.
  • Short Interest

    There is no current short interest data available for MDCX.
  • Dividend Yield

    Medicus Pharma does not currently pay a dividend.

  • Dividend Growth

    Medicus Pharma does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MDCX.
  • News Sentiment

    Medicus Pharma has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Medicus Pharma this week, compared to 2 articles on an average week.
  • Search Interest

    Only 6 people have searched for MDCX on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Medicus Pharma to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medicus Pharma insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $579,000.00 in company stock.

  • Percentage Held by Insiders

    11.20% of the stock of Medicus Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Medicus Pharma's insider trading history.
Receive MDCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter.

MDCX Stock News Headlines

Medicus Pharma Enters Warrant Inducement Agreement
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Headlines

MDCX Stock Analysis - Frequently Asked Questions

Medicus Pharma's stock was trading at $2.43 at the start of the year. Since then, MDCX shares have increased by 28.8% and is now trading at $3.13.

Medicus Pharma Ltd (NASDAQ:MDCX) announced its quarterly earnings results on Monday, May, 12th. The company reported ($0.42) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by $0.19.

Medicus Pharma (MDCX) raised $4 million in an initial public offering (IPO) on Thursday, November 14th 2024. The company issued 1,000,000 shares at $4.13 per share. Maxim Group LLC served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Medicus Pharma's top institutional shareholders include SeaCrest Wealth Management LLC (0.34%).
View institutional ownership trends
.

Shares of MDCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2025
Today
7/14/2025
Next Earnings (Estimated)
7/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDCX
Previous Symbol
NASDAQ:MDCX
CIK
1997296
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$27.00
Low Price Target
$20.00
Potential Upside/Downside
+650.8%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-380.03%
Return on Assets
-224.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.53
Quick Ratio
1.53

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
10.79

Miscellaneous

Outstanding Shares
13,570,000
Free Float
12,053,000
Market Cap
$42.47 million
Optionable
N/A
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:MDCX) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners